Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 49.95 4.17% 2.00
GBT closed up 4.17 percent on Thursday, August 16, 2018, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
6 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GBT trend table...

Date Alert Name Type % Chg
Aug 16 Stochastic Reached Overbought Strength 0.00%
Aug 16 Multiple of Ten Bearish Other 0.00%
Aug 16 Above Upper BB Strength 0.00%
Aug 16 Overbought Stochastic Strength 0.00%
Aug 16 Up 3 Days in a Row Strength 0.00%
Aug 16 Upper Bollinger Band Touch Strength 0.00%
Aug 15 Upside 200 DMA Break Bullish 4.17%
Aug 15 Outside Day Range Expansion 4.17%
Aug 13 Down 3 Days in a Row Weakness 10.63%
Aug 13 Down 4 Days in a Row Weakness 10.63%

Older signals for GBT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Is GBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 16 Today's Research Reports on Trending Tickers: Cronos Group and Global Blood Therapeutics
Aug 15 Investors shun healthcare stocks in broad market selloff
Aug 7 GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
Aug 6 66 Biggest Movers From Friday
Aug 3 56 Stocks Moving In Friday's Mid-Day Session
Aug 3 Global Blood up 6% after Q2 report
Aug 3 Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/03/2018)
Aug 2 Global Blood: 2Q Earnings Snapshot
Aug 2 Global Blood Therapeutics beats by $0.10
Aug 2 GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results
See more GBT news...
Indicators
Indicator Value
52 Week High 68.05
52 Week Low 26.1
Average Volume 1,495,375
200-Day Moving Average 47.0727
50-Day Moving Average 43.621
20-Day Moving Average 44.4475
10-Day Moving Average 46.805
Average True Range 2.4783
ADX 22.84
+DI 33.1037
-DI 12.8796
Chandelier Exit (Long, 3 ATRs ) 44.2651
Chandelier Exit (Short, 3 ATRs ) 47.2849
Upper Bollinger Band 49.6997
Lower Bollinger Band 39.1953
Percent B (%b) 1.02
BandWidth 23.633275
MACD Line 1.3665
MACD Signal Line 0.8127
MACD Histogram 0.5537
Fundamentals Value
Market Cap 2.18 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -20.30
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 55.73
Resistance 3 (R3) 55.67 53.68 54.76
Resistance 2 (R2) 53.68 52.21 53.71 54.44
Resistance 1 (R1) 51.82 51.30 52.75 51.88 54.12
Pivot Point 49.83 49.83 50.30 49.86 49.83
Support 1 (S1) 47.97 48.36 48.90 48.03 45.78
Support 2 (S2) 45.98 47.45 46.01 45.46
Support 3 (S3) 44.12 45.98 45.14
Support 4 (S4) 44.18